Buscar por Autor Orbe, J. (Josune)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 45 a 62 de 62 < Anterior 
Fecha de publicaciónTítuloTipoAutor(es)
2001Papel de los antioxidantes en la prevención de la enfermedad cardiovascularArticuloParamo, J.A. (José Antonio); Orbe, J. (Josune); Rodriguez, J.A. (José Antonio)
1999Papel del PAI-1 en los procesos trombóticosArticuloOrbe, J. (Josune); Montes, R. (Ramón); Paramo, J.A. (José Antonio)
2007Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosisArticuloZalba, G. (Guillermo); Fortuño, A. (Ana); Orbe, J. (Josune); San-Jose, G. (Gorka); Moreno, M.U. (María Ujué); Belzunce, M. (Miriam); Rodriguez, J.A. (José Antonio); Beloqui, O. (Óscar); Paramo, J.A. (José Antonio); Diez-Martinez, J. (Javier)
2003Preliminary characterisation of the promoter of the human p22phox gene: identification of a new polymorphism associated with hypertensionArticuloMoreno, M.U. (María Ujué); San-Jose, G. (Gorka); Orbe, J. (Josune); Paramo, J.A. (José Antonio); Beloqui, O. (Óscar); Diez-Martinez, J. (Javier); Zalba, G. (Guillermo)
1998Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese populationArticuloZabalegui, N. (Natalia); Montes, R. (Ramón); Orbe, J. (Josune); Ayape, M.L. (M. L.); Medarde, A. (A.); Paramo, J.A. (José Antonio); Rocha, E. (Eduardo)
2006Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factorsArticuloOrbe, J. (Josune); Beloqui, O. (Óscar); Rodriguez, J.A. (José Antonio); Belzunce, M. (Miriam); Roncal, C. (Carmen); Paramo, J.A. (José Antonio)
2004Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular diseaseArticuloParamo, J.A. (José Antonio); Orbe, J. (Josune); Beloqui, O. (Óscar); Benito-Boilos, A. (Alberto); Colina, I. (Inmaculada); Martinez-Vila, E. (Eduardo); Diez-Martinez, J. (Javier)
2002Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cellsArticuloPerez-Ruiz, A. (Ana); Montes, R. (Ramón); Velasco, F. (Francisco); Lopez-Pedrera, C. (Chary); Paramo, J.A. (José Antonio); Orbe, J. (Josune); Hermida, J. (José); Rocha, E. (Eduardo)
2023Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5PArticuloSaenz-Pipaón, G. (Goren); Jover, E. (Eva); Bent, M.L. (M. Leontien) van der; Orbe, J. (Josune); Rodriguez, J.A. (José Antonio); Fernández-Celís, A. (Amaya); Quax, P.H.A. (Paul H.A.); Paramo, J.A. (José Antonio); Lopez-Andres, N. (Natalia); Martin-Ventura, J.L. (José Luis); Nossent, A.Y. (Anne Yaël); Roncal, C. (Carmen)
2010Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney diseaseArticuloColl, B. (Blai); Rodriguez, J.A. (José Antonio); Craver, L. (Lourdes); Orbe, J. (Josune); Martinez-Alonso, M. (Montserrat); Ortiz, A. (Alberto); Diez-Martinez, J. (Javier); Beloqui, O. (Óscar); Borras, M. (Merce); Valdivielso, J.M. (José M.); Fernandez, E. (Elvira); Paramo, J.A. (José Antonio)
2015Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Ramos, L. (Luis); Caceres, J.J. (Juan J.); Sole-Violan, J. (Jordi); Argueso, M. (Mónica); Jimenez, A. (Alejandro); Borreguero-Leon, J.M. (Juan María); Orbe, J. (Josune); Rodriguez, J.A. (José Antonio); Paramo, J.A. (José Antonio)
2013The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsisArticuloLorente, L. (Leonardo); Martin, M. (Mar); Plasencia, F. (Fátima); Sole-Violan, J. (Jordi); Blanquer, J. (José); Labarta, L. (Lorenzo); Díaz, C. (César); Borreguero-Leon, J.M. (Juan María); Jimenez, A. (Alejandro); Paramo, J.A. (José Antonio); Orbe, J. (Josune); Rodriguez, J.A. (José Antonio); Salido, E. (Eduardo)
2006The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatinArticuloRoncal, C. (Carmen); Orbe, J. (Josune); Belzunce, M. (Miriam); Rodriguez, J.A. (José Antonio); Paramo, J.A. (José Antonio)
2003The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensivesArticuloDiez-Martinez, J. (Javier); Laviades, C. (Concepción); Orbe, J. (Josune); Zalba, G. (Guillermo); Lopez-Salazar, M.B. (María Begoña); Gonzalez, A. (Arantxa); Mayor, G. (Gaspar); Paramo, J.A. (José Antonio); Beloqui, O. (Óscar)
2019Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery DiseaseArticuloRoncal, C. (Carmen); Martínez-Aguilar, E. (Esther); Orbe, J. (Josune); Ravassa, S. (Susana); Fernandez-Montero, A. (Alejandro); Saenz-Pipaón, G. (Goren); Ugarte, A. (Ana); Estella-Hermoso-de-Mendoza, A. (Ander); Rodriguez, J.A. (José Antonio); Fernández-Alonso, S. (Sebastián); Fernandez-Alonso, L. (Leopoldo); Oyarzabal, J. (Julen); Paramo, J.A. (José Antonio)
2005Trombosis arterial y polimorfismos genéticos: demasiados actores, escenario complejoArticuloParamo, J.A. (José Antonio); Lecumberri, R. (Ramón); Orbe, J. (Josune)
2004Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular diseaseArticuloParamo, J.A. (José Antonio); Beloqui, O. (Óscar); Roncal, C. (Carmen); Benito-Boilos, A. (Alberto); Orbe, J. (Josune)
2001Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplastyArticuloOrbe, J. (Josune); Rodriguez, J.A. (José Antonio); Calvo-González, A. (Alfonso); Grau, A. (Andrés); Belzunce, M. (Miriam); Martinez-Caro, D. (Diego); Paramo, J.A. (José Antonio)